Cargando…
Chemical and Genetic Validation of the Statin Drug Target to Treat the Helminth Disease, Schistosomiasis
The mevalonate pathway is essential in eukaryotes and responsible for a diversity of fundamental synthetic activities. 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) is the rate-limiting enzyme in the pathway and is targeted by the ubiquitous statin drugs to treat hypercholesterolemia. Indep...
Autores principales: | Rojo-Arreola, Liliana, Long, Thavy, Asarnow, Dan, Suzuki, Brian M., Singh, Rahul, Caffrey, Conor R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906178/ https://www.ncbi.nlm.nih.gov/pubmed/24489942 http://dx.doi.org/10.1371/journal.pone.0087594 |
Ejemplares similares
-
Quantification and clustering of phenotypic screening data using time-series analysis for chemotherapy of schistosomiasis
por: Lee, Hyokyeong, et al.
Publicado: (2012) -
A multi-dimensional, time-lapse, high content screening platform applied to schistosomiasis drug discovery
por: Chen, Steven, et al.
Publicado: (2020) -
Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target
por: Long, Thavy, et al.
Publicado: (2017) -
Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib
por: Beckmann, Svenja, et al.
Publicado: (2014) -
Cysteine proteases as digestive enzymes in parasitic helminths
por: Caffrey, Conor R., et al.
Publicado: (2018)